Alpha 2.0
Login Register
» Authors » Martin Terhardt

Martin Terhardt

Explore the profile of Martin Terhardt including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 65
Followers 0
Related Specialties
Public Health
Allergy & Immunology
General Medicine
Top 10 Co-Authors
Ole Wichmann
Thomas Harder
Fred Zepp
Judith Koch
Stefanie J Klug
Marianne van der Sande
Anja Takla
Miriam Wiese-Posselt
Marianne Robl-Mathieu
Sabine Wicker
Published In
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
Vaccine
Paediatr Drugs
Dtsch Arztebl Int
Urologe A
Affiliations
Soon will be listed here.
Recent Articles
1.
Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany
Matysiak-Klose D, Santibanez S, Schwerdtfeger C, Koch J, von Bernuth H, Hengel H, et al.
Vaccine . 2018 Nov; 36(52):7916-7922. PMID: 30478003
Passive immunisation with immunoglobulins as post-exposure prophylaxis after contact with measles is recommended by the German Standing Committee on Vaccination (STIKO) particularly for unprotected individuals at high risk of complications...
2.
[The STIKO now recommends the HPV vaccination for boys too]
Klug S, van der Sande M, Terhardt M, Zepp F, Robl-Mathieu M, Meerpohl J, et al.
Urologe A . 2018 Oct; 57(11):1346-1350. PMID: 30324393
No abstract available.
3.
Background paper for the recommendation of HPV vaccination for boys in Germany
Takla A, Wiese-Posselt M, Harder T, Meerpohl J, Robl-Mathieu M, Terhardt M, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2018 Sep; 61(9):1170-1186. PMID: 30167729
No abstract available.
4.
Remschmidt C, Harder T, Wichmann O, Garbe E, Ledig T, Terhardt M, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2016 Nov; 59(12):1606-1622. PMID: 27815578
No abstract available.
5.
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
Hellenbrand W, Koch J, Harder T, Bogdan C, Heininger U, Tenenbaum T, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz . 2015 Oct; 58(11-12):1314-43. PMID: 26487381
In December 2013 Bexsero® became available in Germany for vaccination against serogroup B meningococci (MenB). In August 2015 the German Standing Committee on Vaccination (STIKO) endorsed a recommendation for use...
6.
Survey of pediatricians in Germany reveals important challenges for possible implementation of meningococcal B vaccination
Takla A, Wichmann O, Koch J, Terhardt M, Hellenbrand W
Vaccine . 2014 Oct; 32(48):6349-55. PMID: 25280437
Incidence of invasive meningococcal disease is low in Germany at 0.5 cases/100,000 inhabitants. Serogroup B (MenB) is most common, causing 70% of cases, with highest incidence in infants (5.9/100,000). In...
7.
The efficacy and duration of vaccine protection against human papillomavirus: a systematic review and meta-analysis
Delere Y, Wichmann O, Klug S, van der Sande M, Terhardt M, Zepp F, et al.
Dtsch Arztebl Int . 2014 Sep; 111(35-36):584-91. PMID: 25249360
Background: The German Standing Committee on Vaccination (STIKO) recommends vaccination against human papillomaviruses (HPV) of the high-risk types 16 and 18. The duration of protection afforded by HPV vaccines has...
8.
Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany
Muehlhans S, von Kleist M, Gretchukha T, Terhardt M, Fegeler U, Maurer W, et al.
Paediatr Drugs . 2014 May; 16(4):321-30. PMID: 24849291
Objectives: Vaccine safety surveillance is highly dependent on accurate reporting of adverse events following immunization (AEFI). An online survey was conducted to assess the utilization of AEFI reporting standards and...